Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Morinaga Milk Industry Co., Ltd. is managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are assigned to 2 distinct examiners and 2 distinct art units. HOFFMAN, SUSAN COE is the busiest examiner, holding 1 busiest examiner pending action. This distribution shows that each of the 2 pending office actions is being reviewed by a different examiner in a different art unit.
The 1 busiest examiner pending action represents a portion of the total 2 pending office actions. Practitioners should prepare for 2 distinct examiner styles across these 2 distinct art units. This separation of the 2 pending office actions suggests that the company's current filings cover different technical sub-sectors. The involvement of 2 distinct examiners requires a coordinated strategy to ensure consistency across the portfolio. Each of the 2 pending office actions is situated in its own 1 distinct art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| §102 only | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOFFMAN, SUSAN COE | 1 | 54.2% | +25.6% |
| GALSTER, SAMUEL LEONARD | 1 | 50.9% | +43.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18702300 | Composition for Promoting the Assimilation of an Oligosaccharide | HOFFMAN, SUSAN COE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18256080 | Prebiotic Composition for Butyric Acid Bacteria | GALSTER, SAMUEL LEONARD | 70d overdue |
| 18702300 | Composition for Promoting the Assimilation of an Oligosaccharide | HOFFMAN, SUSAN COE | — |
| Art Unit | Apps |
|---|---|
| 1655 | 1 |
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18702300 | Composition for Promoting the Assimilation of an Oligosaccharide | HOFFMAN, SUSAN COE | 1655 | §101§102§103§112 | Non-Final OA | — | Pending | Apr 17, 2024 |
| 18256080 | Prebiotic Composition for Butyric Acid Bacteria | GALSTER, SAMUEL LEONARD | 1693 | §102 | Final Rejection | 70d overdue | Pending | Jun 06, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial